ADIPOQ and renal cell carcinoma: No association was found between adiponectin and pancreatic cancer (OR = 1.10 [95% CI = 0.91‐1.34]; P = .32), RCC (OR = 0.93 [95% CI = 0.79‐1.08]; P = .33), ovarian cancer (OR = 1.07 [95% CI = 0.96‐1.19]; P = .22) and endometrial cancer (OR = 1.02 [95% CI = 0.89‐1.17]; P = .75).